239 related articles for article (PubMed ID: 32410138)
21. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF
PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735
[TBL] [Abstract][Full Text] [Related]
22. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.
Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C
PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446
[TBL] [Abstract][Full Text] [Related]
23. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
26. [Expression of neprilysin gene is associated with methylation and histone modification on promoter in mouse neuroblastoma Neuro-2a cells].
Deng Y; Lu X; Liu L; Li T; Zhang Y; Guo X; Yu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):810-3. PubMed ID: 25108432
[TBL] [Abstract][Full Text] [Related]
27. Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.
González A; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Mateos S; Hill SM; Sánchez-Barceló EJ; Cos S
Oncol Rep; 2007 Apr; 17(4):947-53. PubMed ID: 17342341
[TBL] [Abstract][Full Text] [Related]
28. Effect of trichostatin A and 5-Aza-2'-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells.
Kong Q; Wu M; Wang Z; Zhang X; Li L; Liu X; Mu Y; Liu Z
Mol Cell Biochem; 2011 Sep; 355(1-2):157-65. PubMed ID: 21541675
[TBL] [Abstract][Full Text] [Related]
29. Distribution of melatonin receptors in murine pancreatic islets.
Nagorny CL; Sathanoori R; Voss U; Mulder H; Wierup N
J Pineal Res; 2011 May; 50(4):412-7. PubMed ID: 21355877
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms.
Das A; Wallace G; Reiter RJ; Varma AK; Ray SK; Banik NL
J Pineal Res; 2013 Jan; 54(1):58-68. PubMed ID: 22823500
[TBL] [Abstract][Full Text] [Related]
31. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos.
Saini M; Selokar NL; Agrawal H; Singla SK; Chauhan MS; Manik RS; Palta P
Reprod Fertil Dev; 2016 Apr; 28(6):824-37. PubMed ID: 25409339
[TBL] [Abstract][Full Text] [Related]
32. Real-Time Determination of Intracellular cAMP Reveals Functional Coupling of G
Tse LH; Cheung ST; Lee S; Wong YH
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474167
[TBL] [Abstract][Full Text] [Related]
33. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
34. Expression of melatonin (MT1, MT2) and melatonin-related receptors in the adult rat testes and during development.
Izzo G; Francesco A; Ferrara D; Campitiello MR; Serino I; Minucci S; d'Istria M
Zygote; 2010 Aug; 18(3):257-64. PubMed ID: 20109269
[TBL] [Abstract][Full Text] [Related]
35. Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2'-deoxycytidine in glioma cells.
Oi S; Natsume A; Ito M; Kondo Y; Shimato S; Maeda Y; Saito K; Wakabayashi T
J Neurooncol; 2009 Mar; 92(1):15-22. PubMed ID: 19030781
[TBL] [Abstract][Full Text] [Related]
36. Decreased MT1 and MT2 melatonin receptor expression in extrapineal tissues of the rat during physiological aging.
Sánchez-Hidalgo M; Guerrero Montávez JM; Carrascosa-Salmoral Mdel P; Naranjo Gutierrez Mdel C; Lardone PJ; de la Lastra Romero CA
J Pineal Res; 2009 Jan; 46(1):29-35. PubMed ID: 18513209
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells.
Morita K; Gotohda T; Arimochi H; Lee MS; Her S
J Neurosci Res; 2009 Aug; 87(11):2608-14. PubMed ID: 19360904
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
Mori T; Kim J; Yamano T; Takeuchi H; Huang S; Umetani N; Koyanagi K; Hoon DS
Cancer Res; 2005 Mar; 65(5):1800-7. PubMed ID: 15753377
[TBL] [Abstract][Full Text] [Related]
39. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic mechanisms are involved in the regulation of ethanol consumption in mice.
Qiang M; Li JG; Denny AD; Yao JM; Lieu M; Zhang K; Carreon S
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25522411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]